logo-loader
viewAlliance Pharma PLC

'It's never been so busy and exciting', says Alliance Pharma PLC CEO

Alliance Pharma plc (LON:APH) said revenues had more than doubled and trading profits for the year to the end of December were in line with City forecasts as it provided investors with a progress report.

The speciality pharma company said it expects sales to be £97.5mln - up from £48.3mln a year earlier.

CEO John Dawson tells Proactive: 'It's never been so busy and exciting - the prospects are really good.''

Quick facts: Alliance Pharma PLC

Price: 71.8 GBX

AIM:APH
Market: AIM
Market Cap: £373.04 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Alliance Pharma PLC named herein, including the promotion by the Company of Alliance Pharma PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Director's Dealing

1 week, 6 days ago

Total Voting Rights

2 weeks, 5 days ago

Interim Results

4 weeks ago

Total Voting Rights

on 09/03/2019

Total Voting Rights

on 08/02/2019

Half Year Trading Update

on 07/17/2019

Total Voting Rights

on 07/01/2019

2 min read